Pan Thin

496 total citations · 1 hit paper
16 papers, 102 citations indexed

About

Pan Thin is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Pan Thin has authored 16 papers receiving a total of 102 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 15 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Oncology. Recurrent topics in Pan Thin's work include Radiopharmaceutical Chemistry and Applications (15 papers), Prostate Cancer Treatment and Research (15 papers) and Prostate Cancer Diagnosis and Treatment (6 papers). Pan Thin is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (15 papers), Prostate Cancer Treatment and Research (15 papers) and Prostate Cancer Diagnosis and Treatment (6 papers). Pan Thin collaborates with scholars based in United States, Italy and Germany. Pan Thin's co-authors include Jérémie Calais, Kathleen Nguyen, Johannes Czernin, Wesley R. Armstrong, J Gartmann, Ken Herrmann, Matthew B. Rettig, Matthias Eiber, Andrei Gafita and Magnus Dahlbom and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Pan Thin

14 papers receiving 102 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PSMA-PET/CT Findings in Patients With High-Risk Biochemically Recurrent Prostate Cancer With No Metastatic Disease by Conventional Imaging

2025 19 citations Adrien Holzgreve, Wesley R. Armstrong et al. JAMA Network Open profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pan Thin United States	6	89	62	22	19	8	16	102
Lyn Chan Australia	6	56 0.6×	59 1.0×	37 1.7×	7 0.4×	9 1.1×	6	93
Shaojun Zhu United States	5	73 0.8×	78 1.3×	42 1.9×	11 0.6×	9 1.1×	8	108
Javad Saghebi Australia	2	37 0.4×	29 0.5×	20 0.9×	11 0.6×	9 1.1×	8	50
Sophie Tisi United Kingdom	6	142 1.6×	53 0.9×	33 1.5×	11 0.6×	15 1.9×	24	176
Shalini Subramaniam Australia	5	72 0.8×	56 0.9×	39 1.8×	10 0.5×	13 1.6×	16	86
Ashley Mishoe United States	3	50 0.6×	64 1.0×	33 1.5×	8 0.4×	8 1.0×	5	106
Felix Feng United States	1	107 1.2×	80 1.3×	13 0.6×	17 0.9×	3 0.4×	2	114
L HABELSON WILF United States	3	107 1.2×	114 1.8×	17 0.8×	12 0.6×	8 1.0×	5	154
Jenna Mitchell Australia	4	41 0.5×	28 0.5×	36 1.6×	12 0.6×	4 0.5×	5	57
Juan Pablo Sade Argentina	6	56 0.6×	27 0.4×	32 1.5×	10 0.5×	14 1.8×	16	100

Countries citing papers authored by Pan Thin

Since Specialization

Citations

This map shows the geographic impact of Pan Thin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pan Thin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pan Thin more than expected).

Fields of papers citing papers by Pan Thin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pan Thin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pan Thin. The network helps show where Pan Thin may publish in the future.

Co-authorship network of co-authors of Pan Thin

This figure shows the co-authorship network connecting the top 25 collaborators of Pan Thin. A scholar is included among the top collaborators of Pan Thin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pan Thin. Pan Thin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Holzgreve, Adrien, Wesley R. Armstrong, Matthias Benz, et al.. (2025). PSMA-PET/CT Findings in Patients With High-Risk Biochemically Recurrent Prostate Cancer With No Metastatic Disease by Conventional Imaging. JAMA Network Open. 8(1). e2452971–e2452971. 19 indexed citations breakdown →

Murthy, Vishnu, Andrew Nguyen, Timothy Perk, et al.. (2025). Prognostic Value of AI-Assisted Lesion Tracking on End-of-Treatment PSMA PET in mCRPC Patients Treated with ¹⁷⁷ Lu-PSMA: A Retrospective, Single-Center Study. Journal of Nuclear Medicine. 66(11). 1690–1694.

Hotta, Masatoshi, Kathleen Nguyen, Pan Thin, et al.. (2025). Kinetics of PSMA PET signal after radiotherapy in prostate cancer lesions: A single-center retrospective study. Radiotherapy and Oncology. 207. 110869–110869. 2 indexed citations

Murthy, Vishnu, Timothy Perk, Lucia Chen, et al.. (2024). Baseline PSMA PET/CT as a predictive biomarker for toxicity and patient-reported outcomes in mCRPC patients undergoing ¹⁷⁷Lu-PSMA radioligand therapy.. Journal of Clinical Oncology. 42(16_suppl). e17058–e17058. 1 indexed citations

Hotta, Masatoshi, et al.. (2024). Visual and whole-body quantitative analyses of 68 Ga-DOTATATE PET/CT for prognosis of outcome after PRRT with 177Lu-DOTATATE. Annals of Nuclear Medicine. 38(4). 296–304. 2 indexed citations

Thin, Pan, Masatoshi Hotta, Andrei Gafita, et al.. (2024). Clinical Factors That Influence Repeat⁶⁸Ga-PSMA-11 PET/CT Scan Positivity in Patients with Recurrent Prostate Cancer Under Observation After a Negative⁶⁸Ga-PSMA-11 PET/CT Scan: A Single-Center Retrospective Study. Journal of Nuclear Medicine. 65(10). 1571–1576. 1 indexed citations

Murthy, Vishnu, Andrei Gafita, Pan Thin, et al.. (2023). Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with¹⁷⁷Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis. Journal of Nuclear Medicine. 64(11). 1737–1743. 13 indexed citations

Murthy, Vishnu, Kathleen Nguyen, Pan Thin, et al.. (2023). Associations of quantitative whole-body PSMA-PET metrics with PSA progression status under long-term androgen deprivation therapy in prostate cancer patients: a retrospective single-center study. SHILAP Revista de lepidopterología. 7(1). 18–18. 1 indexed citations

Armstrong, Wesley R., Clayton Smith, Pan Thin, et al.. (2023). PSMA PET findings in an “EMBARK-like” cohort of patients with high-risk non-metastatic hormone-sensitive prostate cancer: A single center post-hoc retrospective analysis.. Journal of Clinical Oncology. 41(16_suppl). 5091–5091. 6 indexed citations

10.

Hotta, Masatoshi, Kathleen Nguyen, Pan Thin, et al.. (2022). Kinetics of PSMA PET uptake in prostate cancer lesions after radiation therapy: A single-center retrospective study.. Journal of Clinical Oncology. 40(6_suppl). 36–36. 3 indexed citations

11.

Calais, Jérémie, Johannes Czernin, Pan Thin, et al.. (2021). Safety of PSMA-Targeted Molecular Radioligand Therapy with ¹⁷⁷Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312). Journal of Nuclear Medicine. 62(10). 1447–1456. 29 indexed citations

12.

Armstrong, Wesley R., Andrei Gafita, Shaojun Zhu, et al.. (2021). The Impact of Monosodium Glutamate on ⁶⁸Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study. Journal of Nuclear Medicine. 62(9). 1244–1251. 11 indexed citations

13.

Calais, Jérémie, J Gartmann, Wesley R. Armstrong, et al.. (2020). Overall survival after ¹⁷⁷Lu-PSMA-617 molecular radiotherapy in patients with metastatic castrate-resistant prostate cancer: Post-hoc analysis of a prospective phase II trial.. Journal of Clinical Oncology. 38(15_suppl). 5549–5549. 3 indexed citations

14.

Armstrong, Wesley R., Pan Thin, Kathleen Nguyen, et al.. (2020). Incidence of local prostate cancer recurrence by 68Ga-PSMA-11 PET/CT is higher after definitive Radiation Therapy than after Radical Prostatectomy: a single center post-hoc retrospective analysis of recurrence patterns of 787 patients.. 61. 41–41. 1 indexed citations

15.

Ma, Tonghui, David Shabsovich, Jesus E. Juarez, et al.. (2020). Impact of 68Ga-PSMA-11 PET/CT on Initial Staging of High-Risk Prostate Cancer Patients: Post-Hoc Analysis of a Prospective Single Center Experience. International Journal of Radiation Oncology*Biology*Physics. 108(3). S30–S30.

16.

Calais, Jérémie, Wolfgang P. Fendler, Matthias Eiber, et al.. (2019). RESIST-PC phase 2 trial: 177Lu-PSMA-617 radionuclide therapy for metastatic castrate-resistant prostate cancer.. Journal of Clinical Oncology. 37(15_suppl). 5028–5028. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact